Characterization and predictors of sleep disturbance in patients with relapsed/refractory chronic lymphocytic leukemia (r/r CLL)

被引：0
|
作者：
Westbrook, Travis D.
Maddocks, Kami J.
Andersen, Barbara L.
机构：
[1] Ohio State Univ, Columbus, OH 43210 USA
[2] Ohio State Univ, James Canc Ctr, Columbus, OH 43210 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
10.1200/jco.2015.33.15_suppl.e18021
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18021
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Combined Ibrutinib and Venetoclax in Patients with Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)
    Jain, Nitin
    Keating, Michael J.
    Thompson, Philip A.
    Burger, Jan A.
    Ferrajoli, Alessandra
    Estrov, Zeev E.
    Borthakur, Gautam M.
    Takahashi, Koichi
    Bose, Prithviraj
    Fowler, Nathan H.
    Kadia, Tapan M.
    Daver, Naval G.
    Konopleva, Marina Y.
    Alvarado, Yesid
    Yilmaz, Musa
    DiNardo, Courtney D.
    Ohanian, Maro
    Pemmaraju, Naveen
    Jabbour, Elias
    Sasaki, Koji
    Kanagal-Shamanna, Rashmi
    Patel, Keyur
    Jorgensen, Jeffrey L.
    Wang, Sa A.
    Garg, Naveen
    Wang, Xuemei
    Sondermann, Katrina
    Cruz, Nichole
    Wei, Chongjuan
    Ayala, Ana
    Plunkett, William
    Kantarjian, Hagop M.
    Gandhi, Varsha
    Wierda, William G.
    BLOOD, 2019, 134
  • [2] Comparative analysis of targeted therapies in relapsed/refractory chronic lymphocytic leukemia (R/R CLL)
    Mato, Anthony
    Roeker, Lindsey
    Eyre, Toby
    Ujjani, Chaitra
    Lamanna, Nicole
    Hill, Brian
    Barr, Paul
    Lansigan, Erick
    Cheson, Bruce D.
    Yazdy, Maryam
    Allan, John
    Rhodes, Joanna
    Kennard, Kaitlin
    Schuster, Steven
    Nabhan, Chadi
    Skarbnik, Alan
    Goy, Andre
    Dorsey, Colleen
    Goodfriend, Julie
    Coombs, Catherine
    Tuncer, Hande H.
    Pagel, John
    Jacobs, Ryan
    Kirkwood, Amy
    Winter, Allison
    Schuh, Anna
    Bailey, Neil
    Sitlinger, Andrea
    Shadman, Mazyar
    Fox, Christopher
    Brander, Danielle
    LEUKEMIA & LYMPHOMA, 2020, 61 : 193 - 195
  • [3] A Systematic Literature Review of Utility Estimates for Patients With Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL)
    Yucel, E.
    Hartley, L.
    Bell, J.
    Wolowacz, S.
    Kamgar, F.
    Hawe, E.
    VALUE IN HEALTH, 2022, 25 (12) : S395 - S395
  • [4] Acquired Mutations in Patients (Pts) with Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL) That Progressed in the ALPINE Study
    Brown, Jennifer R.
    Li, Jessica
    Eichhorst, Barbara F.
    Lamanna, Nicole
    O'Brien, Susan M.
    Tam, Constantine S.
    Qiu, Luqui
    Ramakrishnan, Vanitha
    Huang, Ruiqi
    Shi, Yang
    Idoine, Adam
    Salmi, Tommi
    Cohen, Aileen Cleary
    Shadman, Mazyar
    BLOOD, 2023, 142
  • [5] Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)
    Odetola, Oluwatobi
    Ma, Shuo
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2023, 18 (05) : 130 - 143
  • [6] Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)
    Oluwatobi Odetola
    Shuo Ma
    Current Hematologic Malignancy Reports, 2023, 18 : 130 - 143
  • [7] Phase 2 Study of Acalabrutinib in Ibrutinib-Intolerant Patients with Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)
    Rogers, Kerry A.
    Thompson, Philip A.
    Allan, John N.
    Coleman, Morton
    Sharman, Jeff P.
    Cheson, Bruce D.
    Izumi, Raquel
    Frigault, Melanie M.
    Quah, Cheng
    Raman, Rakesh K.
    Wang, Min Hui
    Kipps, Thomas J.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S282 - S283
  • [8] Acalabrutinib in Patients with Relapsed/Refractory (R/R) and High-Risk, Treatment-Naive (TN) Chronic Lymphocytic Leukemia (CLL)
    Sun, Clare C.
    Nierman, Pia
    Ahn, Inhye E.
    Valdez, Janet
    Lotter, Jennifer
    Soto, Susan
    Herman, Sarah E. M.
    Covey, Todd
    Hamdy, Ahmed
    Izumi, Raquel
    Liu, Dongmei
    Patel, Priti
    Wiestner, Adrian
    BLOOD, 2018, 132
  • [9] A Phase 2 Study of Duvelisib and Venetoclax in Patients with Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL) or Richter's Syndrome (RS)
    Crombie, Jennifer L.
    Ryan, Christine E.
    Ren, Yue
    Tyekucheva, Svitlana
    Carey, Celeste
    Zou, Aaron
    Normilus, Samantha
    Montegaard, Josie
    Soumerai, Jacob D.
    Bhandari, Shruti
    Arnason, Jon E.
    Alencar, Alvaro J.
    Kim, Austin I.
    Parry, Erin M.
    Armand, Philippe
    Fisher, David C.
    Brown, Jennifer R.
    Davids, Matthew S.
    BLOOD, 2024, 144 : 4628 - 4629
  • [10] Comparison of Phase 3 Ibrutinib Results Versus Standard of Care in Sweden in Patients with Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)
    Osterborg, Anders
    Asklid, Anna
    Diels, Joris
    Repits, Johanna
    Soltoft, Frans
    Hansson, Lotta
    Jaeger, Ulrich
    BLOOD, 2015, 126 (23)
12345